BD (BDX) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
Becton Dickinson & Co (BDX) is developing smart medical systems by acquiring AI startups to automate diagnostics. The EV/EBITDA trend over time demonstrates the adaptation of these strategies, where the value 10.20 captures the metric level. Production efficiency is ensured by flexible external component sourcing. High-tier engineers, attracted by strong social guarantees and the significant purpose of their work, maintain the business stability.
Comprehensive metric breakdowns and analytics for bd.com (BDX)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- company total debt and liquidity indicators:
Debt to Equity Becton Dickinson & Co|BDX - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio Becton Dickinson|BDX - Company Aggregate Debts|Debt to Book Capitalization Ratio Becton Dickinson & Company|BDX - Company Long-Term Liabilities|Company Short-Term Debts Becton Dickinson|Quick Liquidity bd.com
- business earnings and investment ratios data:
BDX - Company Profit|Future Profit Becton Dickinson & Co|BDX - Market Price to Net Income Ratio|Future Price to Earnings Becton Dickinson & Co|BDX - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Becton Dickinson & Company|BDX - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Becton Dickinson|BDX - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth bd.com|BDX - Net earnings per share growth this year|Expected earnings per share growth for next year Becton Dickinson & Co
Fundamental company analysis:BDX (Becton, Dickinson and Company)
The historical EV/EBITDA chart for Becton Dickinson & Co (BDX) clearly demonstrates the resilience of the business value amid stable demand for medical consumables. This multiple assesses the total enterprise value relative to its operating profit before depreciation and interest. The calculation combines market capitalization with net debt, allowing for the neutralization of the impact of tax burdens and credit structures. For the investor, this is a reliable tool to confirm the company's status as a cash cow with predictable cash flows.
Competitors of Becton Dickinson & Co (BDX)
EV/EBITDA Multiple ISRG (Intuitive Surgical Inc)|Total Company Value to Operating Income Before Depreciation Ratio Danaher Corporation Inc. (DHR)|STE - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|WST (westpharma.com) - Enterprise Value to Operating Income Before Depreciation|Baxter (BAX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|MASI - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio STVN|TFX (Teleflex Corp) - Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Merit Medical Systems (MMSI)|NVST (envistaco.com) - Business Value to Operating Income Before Depreciation|ICU Medical - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Dentsply Sirona Inc XRAY|LMAT - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|AtriCure Medical (ATRC) - Enterprise Value to EBITDA Ratio|STAA: EV/EBITDA Multiple|Company Value to EBITDA ChromaDex (NAGE)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ZimVie|Enterprise Value to Operating Income Before Depreciation ANGO (AngioDynamics Inc)|Enterprise Value to EBITDA Ratio CERS (Cerus Corp)|Enterprise Value to Operating Income Before Depreciation Ratio TKNO|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Monogram Technologies MGRM|Total Company Value to Operating Income Before Depreciation Ratio Sharps Technology Inc (STSS)|InfuSystem Inc - EV/EBITDA Multiple|UTMD: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|KRMD: EV/EBITDA Multiple|Company Value to EBITDA Nyxoah S.A (NYXH)|MBOT (Microbot Medical Inc.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio pro-dex.com (PDEX)|Enterprise Value to EBITDA Ratio ZTEK (Zentek)|Enterprise Value to Operating Income Before Depreciation Ratio ELUT|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Milestone Scientific Corp MLSS|NEXGEL Inc (NXGL) - Company Value to EBITDA|RVP - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|HBIO (Harvard Bioscience Inc.) - Enterprise Value to Operating Income Before Depreciation|FEMY (Femasys) - Enterprise Value to EBITDA Ratio|Meihua Medical Technologies Co., Ltd. - Business Value to Operating Income Before Depreciation|POAI (Predictive Oncology Inc) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation CJMB (Callan JMB Corp)|EV/EBITDA Multiple ATRI|Total Company Value to Operating Income Before Depreciation Ratio neurometrix.com
